Disc Medicine, Inc. Common Stock
IRONDisc Medicine, Inc. (IRON) is a clinical-stage biopharmaceutical company focused on developing therapies for serious and rare hematologic diseases. The company aims to address unmet medical needs through innovative drug discovery and development, with particular emphasis on conditions related to iron metabolism and anemia.
Company News
Rosen Law Firm is investigating potential securities claims against Putnam Investment Management LLC, Sportradar Group AG, and Disc Medicine Inc., alleging materially misleading business information was issued to investors. Affected investors are encouraged to join class action lawsuits seeking compensation for losses.
The Rosen Law Firm is investigating potential securities claims on behalf of Disc Medicine shareholders after the FDA issued a Complete Response Letter on February 13, 2026, rejecting the company's bitopertin drug application due to uncertainties requiring additional evidence. The rejection caused Disc Medicine's stock to fall 22%. Investors who ...
The Rosen Law Firm is investigating potential securities claims on behalf of Disc Medicine shareholders after the FDA issued a Complete Response Letter on February 13, 2026, regarding the company's bitopertin program, citing uncertainties requiring additional evidence. The stock fell 22% following the announcement. Investors who suffered losses a...
The Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. (NASDAQ: IRON) for allegedly issuing materially misleading business information. The investigation was triggered by an FDA Complete Response Letter on February 13, 2026, regarding the company's bitopertin program, which caused the stock to fall 22%. Invest...
Disc Medicine, Inc. (NASDAQ: IRON) received a Complete Response Letter from the FDA on February 13, 2026, rejecting its bitopertin drug application due to uncertainties requiring additional evidence. The rejection caused the stock to plummet 22%. The Rosen Law Firm is now pursuing a class action lawsuit on behalf of shareholders who suffered loss...
